Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Listerine Total Care Zero is a marketed, over-the-counter, alcohol-free anticavity mouthwash developed by Johnson & Johnson. Its primary active ingredient is sodium fluoride (0.02%), which works by promoting the remineralization of tooth enamel and increasing its resistance to acid-mediated decay. The formulation also includes a signature blend of essential oils—eucalyptol, thymol, menthol, and methyl salicylate—which provide antimicrobial activity against cariogenic oral bacteria and help freshen breath. As an alcohol-free rinse, it is designed to provide the benefits of a multi-action mouthwash without the intense taste associated with ethanol-containing formulations. It is indicated for the prevention of dental caries and has been utilized as a standard marketed comparator in clinical studies evaluating oral hygiene products.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Listerine Total Care Zero.